SUPPLEMENT

H1 FY2026 — Additional analyst information

H1 FY2026PDF · 17 pages728 KB
This pack has been prepared to aid discussion and provide further
supplementary information only and has not been subject to an
external review or audit
# Public

-- 1 of 17 --

CUSTOMERS PER ENTITY
Life Policyholders
December 2025 June 2025 December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019
Individual 459,473 453,418 450,866 449,211 449,300 447,690 449,130 449,020 449,378 448,313 445,813 446,713 452,561 446,475
Invest
Invest - DRO 137,008 137,297 137,441 137,503 137,718 137,189 135,819 134,721 133,741 132,817 131,244 129,606 127,831 124,135
Invest - Other 251,084 241,608 236,055 229,871 225,414 221,273 216,479 212,161 206,778 201,210 195,231 192,615 189,210 185,025
Umbrella (lives) 114,848 101,448 98,188 92,178
Umbrella schemes 548 511 503 480
Group (lives) 652,168 702,521 707,154 711,051 707,756 711,161 680,754 584,081 562,769 576,450 562,440 578,035 551,219 544,443
Group schemes 2,531 2,548 2,581 2,616 2,647 2,663 2,666 2,793 2,844 2,827 2,825 2,797 2,740 2,771
Life NB APE
6 months to 12 months to 6 months to 12 months to 6 months to 12 months to 6 months to 12 months to 6 months to 12 months to 6 months to 12 months to 6 months to 12 months to
R million December 2025 June 2025 December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019
Individual 1,441 2,733 1,441 2,778 1,444 2,663 1,355 2,362 1,204 2,072 1,068 2,126 1,165 2,215
Group 67 87 23 164 75 175 130 181 64 193 94 160 75 97
Umbrella 128 383 192 626
Invest - Recurring 977 1,624 867 1,673 851 1,551 796 1,428 737 1,167 573 1,164 686 1,221
Invest - Single APE1 983 1,806 867 1,627 778 1,500 708 1,493 782 1,570 744 1,508 671 1,382
Total Life APE 3,596 6,633 3,390 6,868 3,148 5,889 2,989 5,463 2,786 5,001 2,478 4,958 2,597 4,915
1 APE shown at 10% of Single premium
Health Members
December 2025 June 2025 December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019
DHMS - Keycare 186,366 189,775 204,847 207,934 226,848 225,517 232,988 232,055 234,421 235,841 230,960 232,714 243,046 240,140
DHMS - Non-Keycare 1,182,021 1,169,413 1,154,532 1,152,395 1,147,016 1,149,861 1,142,556 1,135,853 1,118,591 1,111,545 1,099,553 1,111,079 1,108,674 1,110,401
In-House Schemes 366,017 370,608 356,504 354,944 321,333 319,813 321,838 318,246 316,973 321,613 321,767 319,974 317,408 316,410
Total 1,734,404 1,729,796 1,715,883 1,715,273 1,695,197 1,695,191 1,697,382 1,686,154 1,669,985 1,668,999 1,652,280 1,663,767 1,669,128 1,666,951
Health Lives
December 2025 June 2025 December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019
DHMS - Keycare 308,665 315,406 343,648 350,038 385,906 384,759 398,397 397,595 401,307 404,984 400,108 403,392 420,869 415,436
DHMS - Non-Keycare 2,416,457 2,401,304 2,391,556 2,394,452 2,402,336 2,413,851 2,412,595 2,406,528 2,383,486 2,375,082 2,358,232 2,381,735 2,387,237 2,394,336
In-House Schemes 824,525 813,719 800,093 798,933 710,485 707,406 710,427 704,472 699,342 707,293 704,749 698,534 689,688 686,114
Total 3,549,647 3,530,429 3,535,297 3,543,423 3,498,727 3,506,016 3,521,419 3,508,595 3,484,135 3,487,359 3,463,089 3,483,661 3,497,794 3,495,886
Vitality SA
December 2025 June 2025 December 2024 June 2024 December 2023 June 2023 December 20222 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019
Total Vitality Health,
Vitality Drive and Vitality
Money programme lives
3,306,992 3,157,572 3,038,785 2,922,347 2,822,972 2,652,877 2,498,048 2,348,834 2,242,401 2,163,411 2,122,453 2,065,868 2,060,011 1,987,237
2 restated to include for LA wellness figures
VitalityHealth Members
December 2025 June 2025 December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019
Individual 141,965 141,822 141,014 140,400 138,278 135,117 129,568 124,395 117,007 113,189 108,955 105,915 104,997 101,702
SME 347,827 349,465 344,320 340,983 327,876 310,624 285,865 263,216 238,540 222,961 211,949 212,305 209,509 201,960
Corporate 136,345 131,885 128,241 120,685 112,941 108,191 102,823 99,578 89,881 86,149 80,514 81,124 78,050 70,583
Trust and Cost Plus 19,668 18,496 20,198 20,237 16,448 16,339 14,511 8,698 3,944 2,731 2,639 - - -
Lite 80 - - - - - - - - - - - - -
Total 645,885 641,668 633,773 622,305 595,543 570,271 532,767 495,887 449,372 425,030 404,057 399,344 392,556 374,245
VitalityHealth Lives
December 2025 June 2025 December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019
Individual 265,301 262,888 261,481 260,210 256,527 250,551 238,629 227,684 212,896 204,890 195,996 188,976 186,559 179,811
SME 547,180 550,925 545,424 541,111 522,753 496,299 460,442 429,110 395,777 374,179 357,768 356,907 353,763 342,431
Corporate 217,226 210,225 202,151 191,015 178,163 171,364 163,120 158,890 148,654 143,905 135,218 135,440 131,991 120,157
Trust and Cost Plus 34,671 32,739 35,214 35,163 27,349 26,854 22,673 15,903 6,509 4,066 3,956 - - -
Lite 99 - - - - - - - - - - - - -
Total 1,064,477 1,056,777 1,044,270 1,027,499 984,792 945,068 884,864 831,587 763,836 727,040 692,938 681,323 672,313 642,399
VitalityLife Policies
December 2025 June 2025 December 20243 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019
Policies 837,243 781,548 723,213 679,382 646,564 622,451 593,322 565,778 535,281 517,913 493,970 474,890 458,675 434,678
3 December 2024 has been restated
VitalityLife Lives
December 2025 June 2025 December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019
Lives4 957,864 903,996 852,154 810,050 782,296 764,699 735,137 702,105 669,139 647,020 617,051 594,799 577,965 549,526
4 restated to include unique lives only
Discovery Insure Policies
December 2025 June 2025 December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019
Policies 208,123 208,192 213,762 214,297 215,297 211,223 214,315 213,453 212,570 202,335 191,936 178,517 169,920 159,171
Discovery Bank
December 2025 June 2025 December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019
Primary Clients 1,402,626 1,246,817 1,092,386 958,055 825,069 702,131 581,457 470,220 385,177 331,088 287,183 206,810 61,731 1,476
Total Accounts 3,365,688 2,995,078 2,608,023 2,271,703 1,933,839 1,625,912 1,312,970 1,023,790 793,215 648,546 521,081 357,416 141,660 3,740
2 Membership # Public

-- 2 of 17 --

VALUE OF NEW BUSINESS AT POINT OF SALE VS VALUATION DATE
December 2025
VNB at Point of Sale
R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total
Acquisition Costs and Initial strain (286) (1,622) (879) (1,925) (4,712)
Value of In Force 926 1,966 1,161 2,181 6,234
Cost of Capital (23) (43) (29) (71) (166)
617 301 253 185 1,356
New business contribution to value of in force at valuation date
R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total
Value of In Force 922 1,475 1,093 1,897 5,387
Cost of Capital (23) (43) (28) (70) (164)
899 1,432 1,065 1,827 5,223
June 2025
VNB at Point of Sale
R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total
Acquisition Costs and Initial strain (537) (2,937) (1,653) (3,622) (8,749)
Value of In Force 1,632 3,472 2,324 3,775 11,203
Cost of Capital (45) (74) (62) (119) (300)
1,050 461 609 34 2,154
New business contribution to value of in force at valuation date
R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total
Value of In Force 1,597 2,449 2,210 3,404 9,660
Cost of Capital (43) (74) (63) (110) (290)
1,554 2,375 2,147 3,294 9,370
December 2024
VNB at Point of Sale
R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total
Acquisition Costs and Initial strain (264) (1,446) (808) (1,685) (4,203)
Value of In Force 757 1,721 1,015 1,788 5,281
Cost of Capital (21) (36) (26) (42) (125)
472 239 181 61 953
New business contribution to value of in force at valuation date
R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total
Value of In Force 755 1,277 982 1,642 4,656
Cost of Capital (21) (36) (26) (42) (125)
734 1,241 956 1,600 4,531
June 2024
VNB at Point of Sale
R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total
Acquisition Costs and Initial strain (550) (2,833) (1,560) (1,132) (6,075)
Value of In Force 1,653 3,393 2,051 1,074 8,171
Cost of Capital (52) (79) (63) (70) (264)
1,051 481 428 (128) 1,832
New business contribution to value of in force at valuation date
R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total
Value of In Force 1,615 2,454 1,906 909 6,884
Cost of Capital (51) (79) (60) (68) (258)
1,564 2,375 1,846 841 6,626
3 Value of New Business # Public

-- 3 of 17 --

EV RECONCILIATION TO INCOME STATEMENT
for the half year ended 31 December 2025
R million
Embedded
Value
Earnings
Value of In-
Force
Cost of
required
Capital
Impact on
Income
Statement
Adjustment to
Shareholders
Funds
Statement of
Changes in
Equity
Total profit from new business (at point of sale) 1,356 5,393 (166) (3,871)
- Health and Vitality 617 899 (23) (259) - -
- Life 301 1,473 (43) (1,129) - -
- VitalityHealth 253 1,124 (29) (842) - -
- VitalityLife 185 1,897 (71) (1,641) - -
Profit from existing business
Expected return 5,225 294 26 4,905
- Health and Vitality 1,886 143 6 1,737
Expected transfer from VIF to net worth - (1,737) - 1,737
Unwinding of the risk discount rate 1,886 1,880 6 -
- Life 2,287 694 34 1,559
Expected transfer from VIF to net worth - (1,559) - 1,559
Unwinding of the risk discount rate 2,287 2,253 34 -
- VitalityHealth 562 (498) (15) 1,075
Expected transfer from VIF to net worth - (1,075) - 1,075
Unwinding of the risk discount rate 562 577 (15) -
- VitalityLife 490 (45) 1 534
Expected transfer from VIF to net worth - (534) - 534
Unwinding of the risk discount rate 490 489 1 -
Change in methodology and assumptions 5,679 3,787 (30) 1,922
- Health and Vitality 1,563 1,544 19 -
- Life 4,028 3,459 (36) 605
- VitalityHealth - - - -
- VitalityLife 88 (1,216) (13) 1,317
Experience variances 2,417 1,766 82 569
- Health and Vitality 550 282 (5) 273
- Life 1,080 1,009 4 67
- VitalityHealth 539 45 87 407
- VitalityLife 248 430 (4) (178)
Increase in goodwill and intangibles (179) - - - (179) -
Other initiatives 1,174 - - 1,174 - -
Non-recurring expenses (187) - - (187) - -
Acquisition costs (23) - - (23) - -
Finance costs (1,518) - - (1,518) - -
Other (14) 1 - 4 (19) -
Foreign Exchange Rate Movements (4,018) (2,966) 100 1,136 324 (2,612)
Intangibles 324 - - - 324 -
Other (4,342) (2,966) 100 1,136 - (2,612)
Return on shareholders' funds 644 - - 684 - (40)
Unrealised gain on investments and realised gain on investments
transferred to income statement 510 - - 550 - (40)
Health and Vitality investment income 46 - - 46 - -
Life investment income 88 - - 88 - -
VitalityHealth investment income - - - - - -
VitalityLife investment income - - - - - -
Amortisation of Intangibles (30) - - (266) 236 -
Amortisation of intangibles from business combinations (30) - - (42) 12 -
Amortisation of systems intangibles - - - (224) 224 -
VitalityHealth and VitalityLife DAC and unemployment reserve - - - (151) 151 -
Reversal of 1 Discovery Place IFRS 16 financial lease accounting - - - (31) 31 -
Life assets under insurance contracts - - - 1,610 (7,024) 5,414
VitalityLife net assets under insurance contracts - - - (424) (29) 453
VitalityHealth Insurance Acquisition Cash Flow (IACF) asset - - - (77) 77 -
Equity settled share based payment mark-to-market adjustment - - - 303 (303) -
Embedded value earnings 10,526 8,275 12 5,759 (6,735) 3,215
Adjustment to Shareholders' Funds:
Change in: *
VitalityHealth Insurance Acquisition Cash Flow (IACF) asset 227
Intangibles & Goodwill 363
Life net assets under insurance contracts (7,024)
VitalityLife net assets under insurance contracts (29)
1 DP IFRS 16 financial lease accounting 31
Equity settled share based payment mark-to-market adjustment (303)
* The total change in the net assets under insurance contracts consists of the change in the Negative Rand Reserve (NRR), which is zeroised in the embedded value. The change in the NRR is split
between the Income Statement and the change in the Insurance Finance Reserve, which flows through the Statement of Changes in Equity (SOCIE).
4 EV recon # Public

-- 4 of 17 --

EV BUILD-UP PER ENTITY
for the half year ended 31 December 2025
R million Health and Vitality Life and Invest VitalityHealth VitalityLife Other Total
Value of in-force business at 30 June 2025 27,447 41,255 17,869 14,944 - 101,515
Expected return (in-force business) 1,864 2,249 550 457 - 5,120
Release of profits (in-force business) (1,737) (1,559) (1,075) (534) - (4,905)
Value of new business 903 1,923 1,132 2,110 - 6,068
Expected return (new business) 22 38 12 33 - 105
Release of profits (new business) (27) (493) (37) (284) - (841)
Experience variances 277 1,013 132 426 - 1,848
Methodology changes 1,563 3,423 - (1,229) - 3,757
Other1 - - (1,552) (1,314) - (2,866)
Value of in-force business at 31 December 2025 30,312 47,849 17,031 14,609 - 109,801
Shareholders’ funds per Balance Sheet 2,869 39,476 10,060 5,521 15,512 73,438
Adjustment to shareholders' funds - (28,357) (4,893) (11,698) (2,447) (47,395)
Embedded value at 31 December 2025 33,181 58,968 22,198 8,432 13,065 135,844
1 This line includes the impact of foreign exchange rate movements
5 EV Buildup per Entity # Public

-- 5 of 17 --

COMPONENTS OF ASSETS UNDER INSURANCE CONTRACTS AND ADJUSTMENT TO
SHAREHOLDERS' FUNDS ON PUBLISHED BASIS
R million December 2025
1. Assets under insurance contracts
Discovery Life positive liabilities not netted off with negative liabilities: 588
Discovery Life long term reserves in respect of policies with net negative liabilities: (41,744)
Working capital 233
Discovery Life liability for incurred claims (LIC) 8,021
Total Assets under insurance contracts: (32,902)
2. Negative liabilites not included under assets under insurance contracts
Negative reserve in respect of Invest business (7,937)
DAC and DRL in respect of Invest business (854)
(8,791)
3. Components to be zeroised based on the Method of Distributable Cashflows:
Discovery Life long term reserves in respect of policies with net negative liabilities: (41,744)
Liabilities under reinsurance contracts* 985
Negative reserve in respect of Invest business (7,937)
DAC and DRL in respect of Invest business (854)
Adjust for reduction on Deferred Tax Liability as a result of reduction in earnings 9,566
Liabilities off set against Negative reserve before zeroisation 11,627
(28,357)
* This amount is the liability under reinsurance contracts, net of CSM, in respect of the portion of the gross assets under insurance contracts zeroised based on the
method of distributable cashflows.
4. Other adjustments to published Shareholders' funds
VitalityLife net assets under insurance contracts (11,692)
VitalityHealth Insurance Acquisition Cash Flow (IACF) asset (4,893)
VitalityLife receivable relating to the Unemployment Cover benefit (net of deferred tax) (6)
Goodwill (2,756)
Intangible assets (net of deferred tax) relating to the acquisition of Standard Life Healthcare and the Prudential Assurance
Company joint venture (707)
Net preference share capital (779)
Reversal of 1 Discovery Place IFRS 16 financial lease accounting 1,581
Equity settled share based payment mark-to-market adjustment 214
Adjustment to Shareholders' funds from published basis (47,395)
6 EV Adjustment to SH funds # Public

-- 6 of 17 --

RECONCILIATION TO THE REQUIRED CAPITAL
for the half year ended 31 December 2025
R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total
Opening - 30 June 2025 1,286 29,349 4,761 13,050 48,446
- Methodology and Basis Changes - 4,148 - (23) 4,125
- Expected release on in-force at start of period (52) (254) (54) (317) (677)
- Impact of new business written 64 417 263 1,431 2,175
- Other changes* (2) 1,091 (398) 153 844
- Exchange rate movements - - (397) (1,152) (1,549)
Change in Required Capital 10 5,402 (586) 92 4,918
Closing - 31 December 2025 1,296 34,751 4,175 13,142 53,364
*This line includes, amongst other things, the impact of rebasing the yield curve as part of the opening to closing reconciliation of required capital. This component
of the expected yield curve unwind is shown separately from the expected release for information purposes only.
7 Recon of Required Capital # Public

-- 7 of 17 --

BREAKDOWN OF INVEST AND UMBRELLA ASSETS UNDER ADMINISTRATION
R million Invest Umbrella
December 2021 127,632
June 2022 121,737
December 2022 130,830
June 2023 140,378
December 2023 144,810
June 2024 154,653 17,074
December 2024 166,915 18,196
June 2025 178,744 22,487
December 2025 199,820 25,436
8 Invest and Umbrella AUA # Public

-- 8 of 17 --

SA SA SA SA SA UK UK ALL OTHER SEGMENT IFRS
R million HEALTH LIFE INVEST INSURE BANK HEALTH LIFE SEGMENTS TOTAL TOTAL
31 December 2025
Income statement
Insurance revenue 369 9,798 2,399 3,207 - 10,498 4,429 - 30,700 - 30,700
- Contracts measured under the General measurement model/Variable fee approach - 7,912 2,399 - - - 4,429 - 14,740 - 14,740
- Contracts measured under Premium allocation approach 369 1,886 - 3,207 - 10,498 - - 15,960 - 15,960
Insurance service expenses (260) (7,713) (1,570) (2,718) - (8,963) (3,845) 5 (25,064) - (25,064)
- Claims and benefits (184) (5,562) (342) (1,416) - (5,911) (1,824) 6 (15,233) - (15,233)
- Insurance service expense and other (45) (930) (742) (847) - (1,960) (334) (1) (4,859) - (4,859)
- Insurance acquisition cash flows (31) (1,221) (486) (455) - (1,092) (1,687) - (4,972) - (4,972)
Tax specific to policyholder tax funds - - (51) - - - - - (51) 51 -
Insurance service result (pre-reinsurance) 109 2,085 778 489 - 1,535 584 5 5,585 51 5,636
Net expenses from reinsurance contracts (1) (525) - (58) - 3 (378) (2) (961) - (961)
- Reinsurance expense (1) (2,016) - (59) - (2) (4,650) - (6,728) - (6,728)
- Insurance claims recovered from reinsurers - 1,491 - 1 - 5 4,272 (2) 5,767 - 5,767
Insurance service result 108 1,560 778 431 - 1,538 206 3 4,624 51 4,675
Net financial result from insurance finance income and expense - 1,430 (14,072) (19) - - 118 - (12,543) 73 (12,470)
- Net finance income/(expense) from insurance contracts - 1,371 (14,072) (19) - - 315 - (12,405) 73 (12,332)
- Net finance expense from reinsurance contracts - 59 - - - - (197) - (138) - (138)
Investment income using the effective interest rate method 9 18 44 155 - 102 36 16 380 146 526
Net fair value gains on financial instruments at fair value through profit or loss - 2,958 14,870 - 33 28 - - 17,889 4,374 22,263
Fair value adjustments to liabilities under investment contracts - (2,678) (695) - - - - - (3,373) 35 (3,338)
Third party interest: fair value adjustments to liabilities under investment contracts - - - - - - - - - (4,068) (4,068)
Net insurance and investment results 117 3,288 925 567 33 1,668 360 19 6,977 611 7,588
Fee income from administration businesses 4,939 103 715 - - 19 - 1,300 7,076 (50) 7,026
Vitality income - - - - - 16 147 2,932 3,095 (293) 2,802
Net banking fee and commission income - - - - 848 - - (44) 804 186 990
- Banking fee and commission income - - - - 1,334 - - - 1,334 - 1,334
- Banking fee and commission expense - - - - (486) - - (44) (530) 186 (344)
Net banking interest and similar income - - - - 590 - - - 590 - 590
- Banking interest and similar income using the effective interest rate - - - - 1,243 - - - 1,243 - 1,243
- Banking interest and similar expense using the effective interest rate - - - - (653) - - - (653) - (653)
Other income 960 93 - 31 25 - - 7,737 8,846 (7,825) 1,021
Non-insurance revenue and income 5,899 196 715 31 1,463 35 147 11,925 20,411 (7,982) 12,429
Net income 6,016 3,484 1,640 598 1,496 1,703 507 11,944 27,388 (7,371) 20,017
Non-insurance acquisition costs - - (257) - - - - (102) (359) 171 (188)
Expected credit losses - - - - (150) - - - (150) - (150)
Marketing and administration expenses (3,888) (391) (399) (112) (1,271) (517) (156) (11,985) (18,719) 7,627 (11,092)
Share of net profits from equity-accounted investments - - - 60 - - 1 670 731 (24) 707
Normalised profit/(loss) from operations 2,128 3,093 984 546 75 1,186 352 527 8,891 403 9,294
Investment income earned on shareholder investments and cash 47 14 2 7 - - - 76 146 (146) -
Intercompany investment income - - - - - - - 706 706 (706) -
Net fair value gains on financial instruments at fair value through profit or loss - 53 37 - - - - 35 125 (125) -
Amortisation of intangibles from business combinations - - - (24) - - - (39) (63) 63 -
Market rentals related to Head Office building adjusted for finance costs and depreciation - - - - - - - (25) (25) 25 -
Interest expenses on borrowings and lease liabilities (1) - - - - (9) (57) (736) (803) (134) (937)
Intercompany finance expenses on borrowings (233) - - - - - (237) (236) (706) 706 -
Foreign exchange (losses)/gains - - - - - - - (83) (83) - (83)
Profit/(loss) before income tax 1,941 3,160 1,023 529 75 1,177 58 225 8,188 86 8,274
Income tax expense (518) (853) (551) (138) (28) (295) (39) (7) (2,429) (86) (2,515)
Profit/(loss) for the year 1,423 2,307 472 391 47 882 19 218 5,759 - 5,759
Profit attributable to:
Ordinary shareholders 1,424 2,307 472 391 47 882 19 174 5,716 - 5,716
Preference shareholders - - - - - - - 44 44 - 44
Non-controlling interest (1) - - - - - - - (1) - (1)
Material items of expenses
Depreciation and amortisation (92) (1) (13) (1) (206) - (30) (640) (983) (143) (1,126)
Derecognition of intangible assets and property and equipment - - - (4) - - - (29) (33) - (33)
Impairment of intangible assets and property and equipment - - - - - - - - - - -
Staff costs (1,549) (196) (137) (39) (542) - - (4,311) (6,774) 210 (6,564)
Other expenses (2,247) (194) (249) (68) (523) (517) (126) (7,005) (10,929) 7,560 (3,369)
(3,888) (391) (399) (112) (1,271) (517) (156) (11,985) (18,719) 7,627 (11,092)
Segment information
IFRS REPORTING
ADJUSTMENTS
# Public

-- 9 of 17 --

VIF, APE AND VNB SPLIT BETWEEN LIFE AND INVEST
R million December 2025 June 2025 December 2024 June 2024 December 2023 June 2023 December 2022 June 2022
VIF1
Life 32,654 27,910 27,082 24,138 22,859 22,244 23,133 22,059
Invest 15,194 13,346 12,715 11,675 10,429 9,393 9,521 8,505
APE
Life 411 735 355 804 426 823 463 837
Invest 1,467 2,535 1,234 2,411 1,150 2,142 1,033 2,158
VNB1
Life 138 113 94 225 136 162 169 364
Invest 163 349 145 256 106 267 160 341
1 These VIF and VNB numbers are after allowing for the Cost of required Capital.
10 Results split Life and Invest # Public

-- 10 of 17 --

Group Shareholder Free Cash Movement
R millions H1 FY2026 FY2025 H1 FY2025 FY2024 H1 FY2024
Cash Generated from In-Force Before Financing and Tax 9,652 17,655 8,319 14,617 7,567
New Business Net of External Financing (3,679) (6,791) (3,506) (6,823) (3,528)
Tax Paid (1,337) (1,867) (758) (1,522) (792)
Operating Cash Flow 4,636 8,997 4,055 6,272 3,247
New Initiatives 51 (615) (727) (1,025) (776)
Business Development and Other (609) (1,244) (595) (1,580) (864)
Finance Cost Paid (823) (1,691) (899) (1,566) (802)
Dividends Paid (1,407) (1,708) (1,073) (1,270) (783)
Financing and Matching Initiatives (722) (539) (236) (496) (332)
Transactions with Borrowers (Excl. Finance Costs) (182) (1,572) (491) 1,130 (80)
Movement in Shareholder Free Cash 944 1,629 35 1,465 (390)
Remove ordinary dividends paid in period 1,363 1,614 1,026 1,179 740
Add ordinary dividends payable in respect of period (758) (1,951) (588) (1,465) (439)
Movement in Shareholder Free Cash – Dividend Accrual Basis (1) 1,549 1,292 473 1,179 (89)
Movement in Shareholder Free Cash - Excl Transactions with Borrowers and Financing
and Matching Initiatives 1,848 3,740 762 831 22
Operating Cash Flow 4,636 8,997 4,055 6,272 3,247
IFRS Normalised Operating Profit net of Tax Expense (2) 6,508 11,277 5,339 9,170 4,294
Cash Conversion Ratio (2) 71% 80% 76% 68% 76%
Group Shareholder Free Cash Movement - Reconciliation to Profit for the Period
R millions H1 FY2026 FY2025 H1 FY2025 FY2024 (3) H1 FY2024 (3)
Profit for the period 5,759 9,558 4,329 7,549 3,361
Reverse non-cash profit items:
Share of net (profits)/losses from equity accounted investments (732) (1,266) (425) (1,031) (302)
Losses/(gains) from dilution of equity accounted investments - 32 26 (22) -
Depreciation and amortisation 1,127 2,177 1,074 2,160 1,040
Impairment of intangible assets 28 131 21 45 4
Deferred acquisition costs (Excl. Invest DAC and exchange rate movements) - - - - -
Movement in contract assets (252) (359) (462) (640) (252)
Amortisation of intangibles from business combinations - - - - -
Non cash impact of Vitality Health DAC (219) (510) (217) (411) (206)
Non-cash fair value gains on financial assets (125) (21) (47) (87) (56)
Non-cash forex gains / losses - 20 - - -
Bank interest income incurred to cash (137) (152) (277) - -
Other non-cash adjustments to profit (89) 54 (22) (151) (65)
Adjustments from IFRS to EV ANW:
Increase in Negative Reserves and Invest DAC (Net of tax) (1,186) (3,181) (1,487) (4,733) (1,784)
Exchange rate movements on Vitality Life Negative Reserves (774) 481 206 (385) (137)
Other adjustments to arrive at EV ANW 59 (279) 404 1,644 137
Incurred to Cash basis:
- Rent Paid (303) (580) (329) (511) (286)
- Finance Costs Paid (1,350) (2,877) (1,494) (2,603) (802)
- Finance Costs Accrued 1,724 3,324 1,711 3,097 1,025
- Taxation paid (1,337) (1,867) (758) (1,522) (792)
- Taxation Accrued 1,221 2,049 654 1,093 810
Investing Activities:
Purchase of property and equipment (145) (294) (120) (414) (246)
Proceeds from disposal of property and equipment 2 3 3 28 -
Purchase of intangible assets (735) (1,682) (875) (1,789) (800)
Increase in investment in associate (3) 463 (11) 287 (176)
Acquisition of business net of cash required - (316) - - -
Cash proceeds from CMT transaction - - (304) - -
Financing Activities:
Increase in borrowings 2,592 3,264 1,765 2,005 500
Repayment of borrowings (2,774) (4,836) (2,257) (874) (580)
Dividends paid to ordinary shareholders (1,363) (1,614) (1,026) (1,179) (739)
Dividends paid to preference shareholders (44) (93) (47) (91) (44)
Movement in Shareholder Free Cash 944 1,629 35 1,465 (390)
Notes
"Movement in Shareholder Free Cash" is an estimate of shareholder free cashflow. Life and Invest and VitalityLife are included based on the change in the Adjusted Net Worth in the Embedded Value. Changes in working capital are not allowed for in the
estimate.
1) This view of the movement in shareholder free cash flow aligns the dividend paid to the period against which the cash flow was generated to fund it. For 31 December 2025, the declared dividend of R758m, per the interim financial results, is used as the
dividend accrued in respect of the six month period.
2) Cash conversion is calculated as Operating Cash Flow per the Group shareholder free cash movement, divided by Normalised Profit from Operations (IFRS total, excluding the IFRS Reporting Adjustments for shareholder investment income and fair value
gains/(losses)) net of Income tax expense (IFRS total) per A.1 Segment Information. "IFRS Normalised Operating Profit net of Tax Expense" and "Cash Conversion" for prior periods have been restated as a result of prior period errors related to movements in Life
net assets under insurance contracts - refer to section D1.1 for more detail. In addition, these items have been restated for prior periods to allow for the reversal of the IFRS Reporting Adjustments for shareholder investment income and fair value gains/(losses)
to better align Normalised Profit from Operations and Operating Cash Flow.
3) Related to note 2 above, "Profit for the period" for H1 FY2024 and FY2024 has been restated. The restatements do not affect the net Movement in Shareholder Free Cash Flow for those periods as they relate to movements in Life net assets under insurance
contracts, which are non-cash flow movements. The offsetting adjustment has been included in "Increase in Negative Reserves and Invest DAC (Net of tax)" in the build-up above.
# Public

-- 11 of 17 --

Reconciliation of operating profit to normalised operating profit
for the half year ended 31 December 2025
Group Group
R million
Half year
ended
December
2025
Half year
ended
December
2024 % change
Operating profit 8,587 7,100 21%
Share of net profits from equity accounted investments 707 399
Impairment of goodwill -
Normalised profit from operations per Segment information (IFRS total) 9,294 7,499 24%
Normalised profit adjustments ( 403) ( 311)
Investment income earned on shareholder investments and cash ( 146) ( 182)
Difference between market related rental and depreciation and finance costs (Head office) ( 109) ( 96)
Tax specific to policyholder tax funds ( 86) ( 55)
Net fair value gains on financial assets at fair value through profit or loss ( 125) ( 78)
Amortisation of intangibles from business combinations 63 54
Restructuring costs - 46
Normalised profit from operations 8,891 7,188 24%
12 Op Profit recon # Public

-- 12 of 17 --

Discovery Bank additional performance metrics
for the six months ended 31 December 2025
2026 H1 2025 H2 2025 H1 2024 H2 2024 H1 2023 H2 2023 H1
Profitability and Efficiency
Retail Net Interest Margin (NIM)* 8.35% 8.85% 9.65% 10.19% 10.06% 9.53% 9.37%
Asset Quality
Non-Performing Loan (NPL) Ratio 4.76% 4.79% 4.92% 5.41% 5.84% 5.02% 4.16%
Capital Adequacy
Common Equity Tier 1 (CET1) Ratio 15.19% 16.31% 16.67% 17.63% 17.07% 16.82% 16.47%
Liquidity
Loan-to-Deposit Ratio (LDR) 42.96% 39.37% 37.05% 35.72% 34.48% 36.08% 23.46%
*Excludes interest on bonds
# Public

-- 13 of 17 --

NAV PER ENTITY
for the six months ended December 2025
Covered businesses December 2025
NAV before adjustment to shareholder funds
Health and Vitality 2,869
Life and Invest 39,476
VitalityHealth 10,060
VitalityLife 5,521
Non-covered businesses
Bank, including DCS intangible asset and goodwill 8,559
Insure 2,738
PAHI 7,659
CMT 1,284
Limited (8,326)
Other 3,598
Total NAV 73,438
# Public

-- 14 of 17 --

# Public

-- 15 of 17 --

Discovery Life - Systematic Interest Rate Movements
# Public

-- 16 of 17 --

Normalised Return on Equity
H1 FY2026 FY2025 H1 FY2025 (1)
EARNINGS
Net profit - attributable to: 5,759 9,558 4,492
- Ordinary shareholders 5,716 9,471 4,448 A
- Preference shareholders 44 93 47
- Non-controlling interest (1) (6) (3)
Earnings adjustments for ordinary shareholders 29 310 63 C=B-A
Normalised headline earnings 5,745 9,781 4,511 B
EQUITY
Opening total equity 65,699 54,451 54,451
- Insurance Finance Reserve (2,928) (4,832) (4,832)
- Perpetual preference share capital 779 779 779
- Non-controlling interest (5) - -
- Other equity 67,854 58,504 58,504 D
Adjusted opening equity 67,854 58,504 58,504 E=D
Closing total equity 73,438 65,699 61,038
- Insurance Finance Reserve 2,940 (2,928) (2,839)
- Perpetual preference share capital 779 779 779
- Non-controlling interest (6) (5) (3)
- Other equity 69,725 67,854 63,101 F
Adjusted closing equity 69,725 67,854 63,101 G=F
Normalised adjusted closing equity 69,754 68,164 63,164 H=G+C
Average normalised equity 68,804 63,334 60,834 I=(H+E)/2
RETURN ON EQUITY Full-year
Normalised return on equity (annualised) 17.4% 15.4% 15.4% =B/I
Notes
1) The Normalised Return on Equity at 31 December 2025 has been restated as a result of prior period errors related to
movements in Life net assets under insurance contracts - refer to section D1.1 for more detail.
# Public

-- 17 of 17 --